title: Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
authors.forename: Viviane
authors.initials: V
authors.lastname: Guerin
authors.forename: Isabelle
authors.initials: I
authors.lastname: Chossat
authors.forename: Herve
authors.initials: H
authors.lastname: Dutronc
authors.forename: Marc
authors.initials: M
authors.lastname: Dubreuil
authors.forename: François
authors.initials: F
authors.lastname: Valentin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D004359:Drug Therapy, Combination; D005167:Factor VII / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa